Dr. Cesar A. Simbaqueba Clavijo, MD
- Medicare services, 2024
- 501
- Medicare patients, 2024
- 169
- Part D claims, 2024
- 59
- MIPS score, 2024
- 84
- Hospital affiliations
- 1
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Simbaqueba Clavijo's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Cesar A. Simbaqueba Clavijo is an internist in Houston, Texas
Dr. Simbaqueba Clavijo practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Simbaqueba Clavijo's NPI, 1548305931, was assigned on February 21, 2007. Dr. Simbaqueba Clavijo holds Pennsylvania license MD453609.
- NPI
- 1548305931NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6305872797
- NPI enumeration date
- February 21, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 55
- Medical school graduation
- 1997
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Cesar A. Simbaqueba Clavijo practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Simbaqueba Clavijo's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Source: Dmand AI Affiliation Data
Dr. Cesar A. Simbaqueba Clavijo is affiliated with 1 site of care and 1 medical group
Dr. Simbaqueba Clavijo's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Cesar A. Simbaqueba Clavijo's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Simbaqueba Clavijo practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Cesar A. Simbaqueba Clavijo is one of 8,437 internists in Texas
Internal medicine is Dr. Simbaqueba Clavijo's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Simbaqueba Clavijo is licensed in Pennsylvania.
Specialties and state licenses
- Internal medicine, PennsylvaniaPrimary
Internists near Dr. Simbaqueba Clavijo
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Cesar A. Simbaqueba Clavijo billed Medicare for 501 services in 2024
CMS data shows 501 Medicare services from Dr. Simbaqueba Clavijo across 4 procedure codes in 2024, for 169 Medicare patients. Medicare paid $46,787 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Simbaqueba Clavijo's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4012024: 50125%
Dr. Simbaqueba Clavijo compared with the Texas median for internists, 2024
- Dr. Simbaqueba Clavijo
- Texas median
- Medicare services
- 501vs 5397% below
- Medicare patients
- 169vs 19011% below
- Part D claims
- 26vs 28991% below
Medians across 7,794 internists in Texas with Dmand AI profiles that report each measure.
Dr. Simbaqueba Clavijo's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Simbaqueba Clavijo?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Simbaqueba Clavijo and other internists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Cesar A. Simbaqueba Clavijo treated 169 Medicare patients in 2024, average age 72
CMS counts 169 Medicare patients who saw Dr. Simbaqueba Clavijo in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Simbaqueba Clavijo's median patient age at 70, with 61% women.
Dr. Simbaqueba Clavijo's Medicare patients by age, 2024
Dr. Simbaqueba Clavijo's Medicare patients by sex, 2024
- Women8249%
- Men8751%
Chronic conditions among Dr. Simbaqueba Clavijo's Medicare patients, 2024
- High blood pressure75%
- High cholesterol69%
- Cancer62%
- Arthritis57%
- Mood disorders51%
- Anxiety49%
- Ischemic heart disease46%
- Chronic kidney disease43%
Share of Medicare patients with each condition. A patient can have several.
Dr. Simbaqueba Clavijo's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women61%
- Men39%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Cesar A. Simbaqueba Clavijo wrote 59 Medicare Part D claims in 2024
In 2024, Dr. Simbaqueba Clavijo wrote 59 Medicare Part D claims for 24 patients. 95% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $5,219 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.
Dr. Simbaqueba Clavijo's Part D claims by kind of drug, 2024
- Generic56 claims95%
- Brand-name and other3 claims5%
Dr. Simbaqueba Clavijo's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Simbaqueba Clavijo's Part D claims, 2024
- Antibiotics22%13 of 59 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 252024: 264%
Drugs named by CMS: 2 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Cesar A. Simbaqueba Clavijo scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Simbaqueba Clavijo for performance year 2024, reported as part of a group. Dr. Simbaqueba Clavijo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Simbaqueba Clavijo's MIPS scores, performance year 2024
- 84of 100Final score
- 70.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 68of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Cesar A. Simbaqueba Clavijo received $377 in industry payments from 2016 to 2018
CMS Open Payments shows 14 general payments to Dr. Simbaqueba Clavijo from 3 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $231.
General payments to Dr. Simbaqueba Clavijo by program year, 2016 to 2018
Companies that paid Dr. Simbaqueba Clavijo the most, 2016 to 2018
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Cesar A. Simbaqueba Clavijo's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Cesar A. Simbaqueba Clavijo
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Cesar A. Simbaqueba Clavijo's NPI number?
Dr. Cesar A. Simbaqueba Clavijo's NPI number is 1548305931. It was assigned on February 21, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Cesar A. Simbaqueba Clavijo?
Dr. Cesar A. Simbaqueba Clavijo is an internist in Houston, Texas. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Cesar A. Simbaqueba Clavijo practice?
Dr. Simbaqueba Clavijo practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Simbaqueba Clavijo's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
What is Dr. Cesar A. Simbaqueba Clavijo's medical license number?
Dr. Simbaqueba Clavijo holds Pennsylvania license MD453609.
Which hospitals is Dr. Cesar A. Simbaqueba Clavijo affiliated with?
Dr. Simbaqueba Clavijo practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
What medical group is Dr. Cesar A. Simbaqueba Clavijo part of?
Dr. Simbaqueba Clavijo is linked to Physicians Referral Service.
Does Dr. Cesar A. Simbaqueba Clavijo accept Medicare?
Yes. CMS data shows Dr. Simbaqueba Clavijo billed Medicare for 501 services in 2024, and Dr. Simbaqueba Clavijo accepts Medicare assignment.
What is Dr. Cesar A. Simbaqueba Clavijo's MIPS score?
Dr. Simbaqueba Clavijo's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. Cesar A. Simbaqueba Clavijo see?
CMS counts 169 Medicare patients who saw Dr. Simbaqueba Clavijo in 2024, with an average age of 72.
What services does Dr. Cesar A. Simbaqueba Clavijo bill to Medicare?
In 2024, Dr. Simbaqueba Clavijo's most billed Medicare services were hospital inpatient care (99233), hospital inpatient care (99223) and hospital inpatient care (99232).
Show 3 more questionsShow fewer questions
What drugs does Dr. Cesar A. Simbaqueba Clavijo prescribe most?
In 2024 Medicare Part D data, Dr. Simbaqueba Clavijo's most prescribed drugs by claims were Famotidine and Lansoprazole.
Has Dr. Cesar A. Simbaqueba Clavijo received payments from drug or device companies?
CMS Open Payments shows $377 in general payments to Dr. Simbaqueba Clavijo from 3 companies from 2016 to 2018. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Cesar A. Simbaqueba Clavijo been practicing?
Dr. Simbaqueba Clavijo graduated from medical school in 1997, 29 years ago.
Selling to internal medicine practices?
See internists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card